The ultimate diagnosis of unexplained dyspnoea on exertion: Stay tuned on invasive cardiopulmonary exercise testing and beyond Marco Guazzi Dyspnoea, generally exacerbated by exercise, is a common and disabling perception that may occur in a wide variety of disorders involving the lungs and the heart. 1 Exertional dyspnoea is per se meaningful and bears a high prognostic significance even when it is not sustained by a specific organ system, but is just the result of a psychogenic reaction. 2, 3 Although the symptom is clearly defined and reproducible, in approximately 20% of cases 1 its aetiology, the related substrate and the definitive diagnosis may remain challenging in a subgroup of patients who are categorised under the definition of 'unexplained dyspnoea'. 4 This has immediate confirmation in the multifactorial and complex origin of symptomatology 1 and related clinical phenotype. 5 Generally, reasons for the complaint of dyspnoea are readily determined by history, physical examination and basic screening tests performed at rest, including electrocardiography (ECG), spirometry, biomarkers and chest radiograph. 6 However, when a cause of dyspnoea is not apparent after initial diagnostic work-up obtained at rest, evaluation under exercise with gas exchange analysis by cardiopulmonary exercise testing (CPET) may offer additional insights enhancing sensitivity and specificity in ascertaining reasons of breathlessness, not only in advanced cases but also in the early subclinical stages. 7 A number of CPET measures and derived variables further help in distinguishing a cardiac, pulmonary or peripheral substrate. While lung diseases can be unmasked in most cases by a thorough analysis of ventilatory mechanics, tidal volume over dead space changes, pressure flow/volume loops and O 2 saturation, identification of pulmonary vascular, cardiac or peripheral mediators of exercise intolerance and dyspnoea sensation is more problematic on the simple basis of a reduced oxygen consumption (VO 2 ) and inefficient ventilation, because of poor specificity. 8 This is especially true in the presence of pulmonary arterial hypertension (PAH) of any origin, heart failure with preserved ejection fraction (HFpEF), deconditioning and mitochondrial myopathy. In these subjects measurement of pulmonary haemodynamics, left ventricular (LV) filling pressures, Fick cardiac output, and O 2 artero-venous difference is essential for addressing the pathophysiological clues of exercise-induced dyspnoea. 9, 10 Invasive CPET (iCPET), combining pulmonary and systemic haemodynamics along with gas analysis, has been proposed as a key examination for the ultimate diagnosis 11 and precise phenotyping 8, 12 of patients with dyspnoea of uncertain origin.
In this issue of the European Journal of Preventive Cardiology, Huang et al. 13 report their experience on iCPET applications in the multidisciplinary process involving a large group of patients who were referred to the Brigham and Women's Hospital Multidisciplinary Dyspnea/Exercise Intolerance Center, USA after inconclusive previous referrals.
The data are attractive and place iCPET as a diagnostic approach for solving a significant rate of cases. In a final population of 530 patients, retrospectively identified, iCPET provided a diagnosis which was quite equally distributed among exercise-induced PAH, HFpEF, dysautonomia, oxidative myopathy and primary hyperventilation. Of note, all of the subjects had already been tested by non-invasive CPET.
These observations indisputably add evidence in favour of iCPET in the formulation of a definitive diagnosis with a specific haemodynamic algorithm to follow, but what really demonstrates the novelty of the present study is the analysis of how much time lag intervenes between symptom manifestation, the number and type of tests performed prior to referral at the Dyspnea Center, and diagnosis. The observational period between dyspnoea manifestation and iCPET time lag was truncated at four years, certainly an impressive time. The analysis was performed on the number of days between dyspnoea complaint and referral to the Dyspnea Center and number of days between referral and final diagnosis. Of note, the median time of the period during which dyspnoea remained undiagnosed was 511 days, whereas the median time for a final diagnosis from the referral period was 27 days.
For reaching a thorough diagnosis, an algorithm is proposed in which iCPET is in a key position for dissecting between a peripheral and a central haemodynamic reason of dyspnoea. In the latter case, pulmonary haemodynamic assessment provides a direction toward a conclusive diagnosis but dispute persists regarding normal reference numbers for proposed cutoff, mainly, considering the significant age-related variations in pulmonary haemodynamics 14 and the lack of general agreement on the cutoff of normalcy, especially regarding mean arterial pulmonary pressure. 15 Presumably, a collection of additional measures, for example measures of biomarkers at rest and during exercise, and knowledge about cardiac rhythm disorders typically affecting elderly patients, such as atrial fibrillation, would have integrated iCPET information and its overall value.
How can we proceed from here on? Despite the new informative evidence on the time-consuming process between symptoms and diagnosis, some crucial questions come up, i.e. how reproducible are pulmonary haemodynamic measures during a maximal functional test and how many laboratories can reliably perform an iCPET reaching a diagnosis in a reasonable time? Also, do alternatives exist to iCPET? Evaluation of pulmonary haemodynamics during exercise may suffer from some technical challenges, mainly because of respiratory pressure swings. Guidelines recommend to perform measurements at end-expiration at rest, but allow for averaging over several respiratory cycles during exercise when respirophasic changes become excessive. 15 Switching from one mode to the other remains undefined and generates uncertainty on measurement.
With these potential limitations in mind, it is undisputable that iCPET adds a level of complexity to noninvasive CPET and increases costs for materials and dedicated personnel. Non-invasive CPET has taken several decades before becoming a test of routine assessment and standardisation in specific populations. 9 It is desirable that iCPET diffusion on a large scale may take less time, but a cost-benefit analysis at this stage would be useful.
While waiting for clarification of this open scenario, it seems a good idea to weigh and balance iCPET against the informative data derived from non-invasive CPET combined with echocardiography, or 'CPET imaging', an approach which has gained some popularity in recent times. [16] [17] [18] Potential advantages of CPET imaging can be summarised in the non-invasive nature, the parallel estimation of pulmonary pressures, left atrium and left ventricular filling dynamics maintaining a good ability to measure cardiac output and its determinants through assessment of the contractile state and relaxation of cardiac chambers with the corresponding contributions of left-sided versus right-sided heart haemodynamics. In addition, in patients with cardiac origin of their symptoms, the study of valve function and pressure gradients adds to the haemodynamic and diagnostic picture.
In conclusion, Huang et al. 13 deserve to be commended. They demonstrate the clinical relevance of iCPET in making a diagnosis before assigning undiagnosed cases to targeted therapy. Study findings pave the way to the search for, and validation of, the in-and out-of-hospital paths that may optimise the huge delay between symptom manifestations and true diagnosis, complying with the patients' best expectations.
Once the reasons for exercise-induced dyspnoea are unclear, iCPET may provide the ultimate test for 'explaining the unexplained'. Thus, stay tuned on the evolving applications of iCPET and . . . (for the above mentioned reasons) even beyond.
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